Co-Diagnostics Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on CODX yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Co-Diagnostics has set a 1-for-25 reverse stock split to take effect on Nov. 24. Holders will see their share count reduced by a factor of 25 on that date.
Co-Diagnostics filed an 8-K reporting material modifications to the rights of security holders, an amendment to its articles or bylaws, and a change in fiscal year. The filing's details are not in the headline, so the specific impact on shareholders is unclear from this item alone.
Co-Diagnostics has announced a 1-for-25 reverse stock split. The headline gives no details on timing or effective date, so holders should check the company's filing for those.
Co-Diagnostics announced it has filed articles of amendment to carry out a reverse stock split of its Nasdaq-listed shares. Holders should check the split ratio and effective date in the full release, since a reverse split changes share count and price.
No SEC financials for CODX yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.